NCT01548560View on ClinicalTrials.gov

Assessing the Safety of Dapivirine Gel and Film Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
HIV Infections
Interventions
DRUG

Dapivirine Vaginal Film

Dosage form: vaginal film Dosage: 1.25mg Frequency: 7 daily doses

DRUG

Dapivirine Vaginal Gel

Dosage form: vaginal gel Dosage: 0.5%, 2.5g Frequency: 7 daily doses

Trial Locations (1)

15213

Magee-Womens Hospital, Pittsburgh

All Listed Sponsors
lead

International Partnership for Microbicides, Inc.

INDUSTRY

NCT01548560 - Assessing the Safety of Dapivirine Gel and Film Formulations | Biotech Hunter | Biotech Hunter